BlackRock Fund Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $15.6M | Buy |
7,359,385
+957,970
| +15% | +$2.03M | ﹤0.01% | 2319 |
|
|
2016
Q3 | $21.4M | Buy |
6,401,415
+404,722
| +7% | +$1.36M | ﹤0.01% | 2032 |
|
|
2016
Q2 | $18.8M | Buy |
5,996,693
+86,207
| +1% | +$271K | ﹤0.01% | 2058 |
|
|
2016
Q1 | $19.7M | Sell |
5,910,486
-6,526,309
| -52% | -$21.7M | ﹤0.01% | 1999 |
|
|
2015
Q4 | $44M | Sell |
12,436,795
-259,248
| -2% | -$918K | 0.01% | 1562 |
|
|
2015
Q3 | $63.9M | Sell |
12,696,043
-269,609
| -2% | -$1.36M | 0.02% | 1259 |
|
|
2015
Q2 | $83.4M | Sell |
12,965,652
-398,269
| -3% | -$2.56M | 0.02% | 1143 |
|
|
2015
Q1 | $94M | Buy |
13,363,921
+1,060,008
| +9% | +$7.46M | 0.02% | 1050 |
|
|
2014
Q4 | $94.9M | Buy |
12,303,913
+760,318
| +7% | +$5.86M | 0.02% | 996 |
|
|
2014
Q3 | $86.2M | Buy |
11,543,595
+159,415
| +1% | +$1.19M | 0.02% | 963 |
|
|
2014
Q2 | $110M | Sell |
11,384,180
-127,315
| -1% | -$1.23M | 0.03% | 799 |
|
|
2014
Q1 | $95.7M | Buy |
11,511,495
+686,216
| +6% | +$5.7M | 0.03% | 878 |
|
|
2013
Q4 | $91.4M | Buy |
10,825,279
+196,489
| +2% | +$1.66M | 0.03% | 905 |
|
|
2013
Q3 | $84.7M | Buy |
10,628,790
+722,942
| +7% | +$5.76M | 0.03% | 893 |
|
|
2013
Q2 | $76.5M | Buy |
+9,905,848
| New | +$76.5M | 0.03% | 851 |
|